Medine GmbH - 31 Mar 2025 SCHEDULE 13G/A Report for BioNTech SE Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)

Filing Manager
Medine GmbH
Reporting Manager
Prof. Ugur Sahin, M.D.
Security
BioNTech SE Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
Symbol
BNTX
Shares outstanding
239,647,920 shares
Disclosed Ownership
42,178,034 shares
Ownership
18%
Form type
SCHEDULE 13G/A
Filing time
13 May 2025, 18:14:13 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Quoteable Key Fact

"Medine GmbH disclosed 18% ownership in BioNTech SE Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) on 31 Mar 2025."

Quick Takeaways

  • Medine GmbH filed SCHEDULE 13G/A for BioNTech SE Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX).
  • Disclosed ownership: 18%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 May 2025, 18:14.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Medine GmbH 17% 40,127,697 0 39,111,390 /s/ Prof. Ugur Sahin, M.D. Prof. Ugur Sahin, M.D./Authorized Signatory
Prof. Ugur Sahin, M.D. 18% 42,178,034 2,050,337 40,127,697 /s/ Prof. Ugur Sahin, M.D. Prof. Ugur Sahin, M.D.